SCHEMBL1425921

SCHEMBL1425921

COc1cc(-c2nc(N)nc3c2CN(Cc2ccc(Cl)cc2)C3)c(Cl)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTT P42858 1/20 0.37
▸ DRD4 P21917 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ GRM2 Q14416 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ CARM1 Q86X55 1/20 0.35
▸ DHFR P00374 1/20 0.34
▸ HSP90AA1 P07900 2/20 0.34
▸ HSP90AB1 P08238 2/20 0.34
▸ ACHE P22303 2/20 0.34
▸ BACE1 P56817 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ STAT3 P40763 1/20 0.34
▸ BCHE P06276 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14135050 0.94 HTT (0.37) DPP4CYP3A4CYP2C19HTTMEN1
SCHEMBL13394094 0.92 CYP3A4 (0.45) DPP4CYP3A4CYP2C19DRD4MEN1
SCHEMBL1425812 0.90 PDE5A (0.39) DPP4CYP3A4CYP2C19HTT
Trifluoroacetic Acid SCHEMBL1425132 0.85 CYP3A4 (0.40) DPP4CYP3A4CYP2C19DRD4MEN1
SCHEMBL1425638 0.84 HSP90AB1 (0.38) DPP4CYP3A4HSP90AA1HSP90AB1
SCHEMBL1425365 0.84 HTR4 (0.35) DPP4CYP3A4POLBHSP90AA1HSP90AB1
SCHEMBL1426051 0.83 SUV39H2 (0.35) DPP4HSP90AA1HSP90AB1
SCHEMBL1425846 0.83 NPBWR1 (0.35) DPP4CYP3A4CYP2C19DRD4BACE1
SCHEMBL13394203 0.82 DPP4 (0.33) DPP4CYP3A4CYP2C19KMT2AHTR2A
SCHEMBL12811523 0.82 HSP90AB1 (0.38) DPP4CYP3A4HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118111-B1 2-AMIN0-5, 7-DIHYDR0-6H- PYRROLO [3, 4-D] PYRIMIDINE DERIVATIVES AS HSP-90 INHIBITORS FOR TREATING CANCER PFIZER (US) 2011-03-23 — — EP disclosed
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS PFIZER INC. 2010-04-15 — — US disclosed
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS PFIZER INC. 2010-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS HSP90AB2P, HSP90AB1, HSP90AA1 DPP4 3302/4885CYP3A4 2698/4885CYP2C19 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback